Dr. Huckfeldt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Massachusetts Eye and Ear Infirmary
243 Charles Street
Boston, MA 02114Phone+1 617-573-3621
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2010 - 2013
- Washington University in St. Louis School of MedicineClass of 2009, MD, PhD
- University of Iowa Hospitals and ClinicsFellowship, Medical Retina
- Newton-Wellesley HospitalInternship, Transitional Year
- University of PennsylvaniaPostdoctoral Research, Ophthalmology
- Massachusetts Eye and EarFellowship, Inherited Retinal Degenerations
Certifications & Licensure
- MA State Medical License 2015 - 2025
- IA State Medical License 2014 - 2016
- PA State Medical License 2013 - 2014
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) Start of enrollment: 2017 Aug 03
- Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Start of enrollment: 2020 Dec 04
Publications & Presentations
PubMed
- 93 citationsEvaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate RetinaPavitra S. Ramachandran, Vivian S. Lee, Zhangyong Wei, Ji Yun Song, Giulia Casal
Human Gene Therapy. 2017-02-01 - 14 citationsNeuroprotection for retinal detachment.Rachel M. Huckfeldt, Demetrios G. Vavvas
International Ophthalmology Clinics. 2013-01-01 - 11 citationsAdeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy Trial.Tomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, Denise J Pearson, Grace K Vergilio
Ophthalmology. 2022-10-01
Press Mentions
- AGTC Reports 12-Month Data from Its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 GeneJune 24th, 2021
- Foundation Fighting Blindness to Jointly Host Online Continuing Medical Education (CME, COPE) WebinarSeptember 24th, 2020
- Mass General Research Awards and Honors: October 2018November 15th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: